Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Globally, a child contracts HIV every 100 seconds. A new, affordable treatment is available, but the COVID-19 pandemic hinders access.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, urges us to learn from HIV.
Young long-term survivors continue to face challenges.
Previously, kids weighing 44 to 88 pounds had to take lower doses—which are less available worldwide—and do so more than once a day.
This is according to a small study that analyzed the difference in rates of viral suppression among children of various ages.
The agency has also lowered the weight threshold for film-coated tablets of the integrase inhibitor.
The International AIDS Conference takes place July 6 to 10 in San Francisco and Oakland.
A new strawberry-flavored HIV med is a game changer for children living with HIV.
“This is excellent news for all children living with HIV.”
A long-term study sought to determine which factors help predict low adherence among young people with the virus.
Changes include new information about risks associated with dolutegravir during pregnancy and removal of older drugs owing to toxicities.
Following a group of Ethiopian children on antiretrovirals, researchers observed declining kidney function but improving liver enzymes.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Researchers argue that among children born to mothers with HIV, other factors such as the virus and substance use prompt such outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.